Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Acceptance based on results from the Phase 3 KEYNOTE-859 trial, which showed significant overall survival benefit in these patients with HER2-negative disease, regardless of PD-L1 expression
Stedycon Sted super-resolution fluorescence microscope
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Cell sorting technology supports researchers advancing new therapies
Point-of-Care solution to facilitate clinicians in quick and effective decision making
The company is one of the most profitable companies manufacturing speciality chemicals in India
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Subscribe To Our Newsletter & Stay Updated